Back to search

Article

Metabolomic and Lipid Alterations are Associated with Longitudinal Neurological Performance in Multiple Sclerosis

2025-07-22

Abstract excerpt

<title>Abstract</title> <p>Metabolomics incorporates information from multiple biological systems and is recognized as an emerging tool for identifying novel multiple sclerosis (MS) biomarkers. While prior studies have linked metabolic alterations to the disease severity in people with MS (pwMS), a longitudinal approach enables a significant advantage to study this relationship over disease progression. Therefore...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6d569c8b-c0d7-5630-b1bd-2b172597cfbe
DOI
10.21203/rs.3.rs-7078057/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Metabolomic and Lipid Alterations are Associated with Longitudinal Neurological Performance in Multiple SclerosisDOI 10.21203/rs.3.rs-7078057/v1
Metabolomics reveals lipid and amino acid signatures of disease severity in multiple sclerosisSemantic proximity
Metabolomic Signatures of Brain Atrophy and Ibudilast Response in Progressive Multiple SclerosisSemantic proximity
Multi-omic Evaluation of Metabolic Alterations in Multiple Sclerosis Identifies Shifts in Aromatic Amino Acid MetabolismSemantic proximity
Utility of an untargeted metabolomics approach using a 2D GC-GC‒MS platform to distinguish relapsing and progressive multiple sclerosisSemantic proximity
Utility of an untargeted metabolomics approach using a 2D GC-GC-MS platform to distinguish relapsing and progressive multiple sclerosisSemantic proximity
Integrative Genetic Analyses of Lipid Metabolism and Multiple Sclerosis Severity Using Metabolome-Wide and Cis-Mendelian RandomizationSemantic proximity
Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosisSemantic proximity
A metabolome-wide Mendelian randomization study prioritizes potential causal circulating metabolites for multiple sclerosis.Semantic proximity
Blood-based untargeted metabolomics in Relapsing-Remitting Multiple Sclerosis revealed the testable therapeutic targetSemantic proximity
Multimodal predictors of disability progression and processing speed decline in relapsing-remitting multiple sclerosisSemantic proximity
Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer’s Disease Neuroimaging Initiative cohortSemantic proximity
Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer’s Disease Neuroimaging Initiative cohortSemantic proximity
Select a neighboring publication to make it the new centre.